Apogee Therapeutics

APGE

Market cap $6.37B

85.37 USD

-1.10

1.27%

At close Updated Apr 28, 4:00 PM EDT

Pre-market

After hours

85.37

0.00

1 day

-1.27%

5 days

-7.76%

1 month

8.45%

3 months

20.77%

6 months

51.42%

Year to date

12.66%

1 year

125.91%

5 years

302.12%

10 years

302.12%

About: Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Employees: 261

Healthcare Biotechnology